COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌

2017 Rebecca Kofod Vinding, MD

  • 2015 Ann-Marie Malby Schoos, MD PhD
    • Thesis_2015_Ann-Marie_Schoos
  • 2014 Marie Kragh, MSc PhD
    • Thesis_2014_Marie-Kragh.pdf
  • 2014 Eskil Kreiner-Møller, MD PhD
    • Thesis_2014_Eskil-Kreiner-Moller
  • 2014 Nadja Hawwa Vissing, MD PhD
    • Thesis_2014_Nadja-Vissing
  • 2014 Anna Hammerich Thysen, Msc PhD
    • Thesis_2014_Anna-Thysen
  • 2013 Charlotte Giwercman Carson MD, PhD
    • Thesis_2013_Charlotte-Giwercman
  • 2013 Anne Louise Bischoff MD, PhD
    • Thesis_2013_Anne-Bischoff
  • 2012 Louise Pedersen, MD, PhD
    • Thesis_2012_Louise-Pedersen
  • 2012 Jakob Stokholm, MD, PhD
    • Thesis_2012_Jakob-Stokholm
  • 2012 Nilofar Følsgaard, MD, PhD
    • Thesis_2012_Nilo-Foelsgaard
  • 2011 Martin Brasholt, MD, PhD
    • Thesis_2011_Martin-Brasholt
  • 2011 Bo Chawes, MD, PhD
    • Thesis_2011_Bo-Chawes
  • 2010 Klaus Bønnelykke, MD, PhD
    • Thesis_2010_Klaus-Bonnelykke
  • 2010 Porntiva Poorisrisak, MD, PhD
    • Thesis_2010_Porntiva-Poorisrisak
  • 2009 Mette N Hermansen, MD, PhD
    • Thesis_2009_Mette-Hermansen
  • 2006 Liselotte B Halkjær, MD, PhD
    • Thesis_2006_Liselotte-Halkjær
  • 2006 Birgitte Boysen Kjær, MD, PhD
  • 2004 Lotte Loland, MD, PhD
    • Thesis_2004_Lotte-Loland
  • 2002 Frederik F Buchvald, MD, PhD
    • Thesis_2002_Frederik-Buchvald
  • 1999 Marianne Stubbe Østergaard, MD, PhD
  • 1993 Jytte Fogh, MD, PhD
  • 2017 Elín Bjarnadóttir, MD PhD
  • 2017 Helene Wolsk, MD
  • 2017 Tine Marie Pedersen, MD
  • 2017 Astrid Sevelsted, MSc
  • 2017 Rebecca Kofod Vinding, MD
  • 2019 Lambang Arianto, MD
  • 2018 Henrik Hallas, MD
  • 2018 Jonathan Thorsen, MD
  • 2018 Nadia Rahman Fink, MD
  • 2019 Christian Carlsson, MD
  • 2019 Christian Carlsson, MD
  • 2019 Ni Wang, MD
  • 2021 Sarah Nørgaard – MSc
  • 2020 Asja Kunøe – MD
  • 2021 Nicklas Brustad – MD
  • 2021 Anders Eliasen – MSc
  • 2021 Lærke Sass – MD
  • 2022 Pia Nørrisgaard – MSc
  • 2022 Emil Christensen – MD
  • 2023 Rikke Sunde – MD
  • 2023 Julie Kyvsgaard – MD
  • 2024 Yang Luo – MSc
  • 2024 Julie Rosenberg – MD
  • 2024 Christina Poulsen – MSc
  • 2024 Parisa Mohammadzadeh – MD
  • 2024 Signe Jensen – MD
  • 2024 David Horner – MD
  • 2025 Liang Chen
  • 2025 Sarah Brandt
  • 2025 Kasper Rasmussen
Home Home Dissemination Theses 2017 Rebecca Kofod Vinding, MD

Early life exposures and childhood growth

By Rebecca Kofod Vinding

Summary

Chariman: Anders Juul

Opponent: Ellen Aagaard Nøhr

Opponent: Jovanna Dahlgren

(PDF)

ABSTRACT

The increased prevalence of overweight children cannot be explained by changes in genetic factors, since the great increase has occurred over a short period of time, the causes must be sought in environmental exposures.

The aim of this thesis is to examine pre and perinatal factors influence on childhood growth in the two birth cohorts Copenhagen Prospective Studies on Asthma in Childhood2000 (COPSAC2000) and COPSAC2010.  We have focused on two exposures in this thesis.

Firstly, caesarean section (CS) which has had an increase in prevalence the last decades. Two recent meta-analyses have shown associations between delivery by CS and obesity in the off-spring in both child- and adulthood.
Secondly, we have focused on maternal dietary n-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) during pregnancy, since it is an important determinant of adequate child development and health. In humans, both observational studies on dietary intake of fish as well as randomized trials of fish oil supplementation in pregnancy have shown longer gestation and higher birth weight in children born to women with a high n-3 LCPUFA intake. However, in humans randomized trials with n-3 LCPUFA supplementation in pregnancy and/or lactation have shown ambiguous results regarding anthropometric outcomes later in childhood.

 

In study I we examined the development of Body Mass Index (BMI) from birth through childhood in children with different delivery mode, to determine if CS were associated with differences in childhood growth and obesity. We collected height/length and weight measurements prospectively from term children until 5 years in COPSAC2010 and 13 years in COPSAC2000, furthermore dual-energy X-ray absorptiometry (DXA) scans were performed at age 3.5 years and 7 years.

We found that children delivered by CS had a higher mean BMI at 6 months compared to those delivered vaginally. However, there were no differences in BMI trajectory between the two groups ages 5 to 13 years, nor cross-sectional at these ages, nor in fat percentages from DXA scans.

In study II we analysed the effect of n-3 LCPUFA supplementation in pregnancy on intrauterine growth, gestational age and birth weight. The study was a double-blinded, RCT. The pregnant women received capsules containing either 2.4 g of n-3 LCPUFA or control daily from pregnancy week 24 until one week after birth.

We found that n-3 LCPUFA compared to control was associated with a longer duration of pregnancy, a higher birth weight and an increased intrauterine growth. We observed no effects on preterm delivery or other pregnancy complications.

In study III we examined the effect of n-3 LCPUFA supplementation in pregnancy on childhood anthropometrics outcomes. The study was nested in the above-mentioned intervention study. We used prospectively collected height/length and weight to examine the development of BMI from birth through 6 years of age. At 6 years we evaluated the cross sectional effect on height, weight, BMI, head and waist measurements. We used data from DXA scans at 3.5 years and 6 years.

We found that the n-3 LCPUFA group had a significantly higher mean z-score BMI from 1 week to 6 years of age compared to the controls, leading to a significantly higher z-score BMI at age 6 years and a larger waist circumference.

From DXA scans, we found a higher total lean soft tissue mass and a higher bone mineral content in the n-3 LCPUFA group. There were not a higher number of children in risk of obesity or with a higher fat percentage at 6 years of age in the n-3 LCPUFA group.

 

In conclusion: our findings have manifested that these exposures during pregnancy and birth are associated with a changed childhood growth.

We saw that children delivered by CS had a higher BMI at 6 months of age, but this did not track into later childhood.

N-3 LCPUFA supplementation from pregnancy week 24 was associated with prolonged gestation and increased intrauterine growth, leading to a higher birth weight. In addition, it led to an increase in BMI from age 1 year to 6 years. It did not lead to a higher number of obese children or a higher fat percentage at 6 years of age.

This thesis adds knowledge to the field regarding early life exposures and metabolic programming. We find associations between two exposures which have been changing during the last decades and childhood growth, both exposures are still modifiable.


CONTACT

COPSAC
Copenhagen Prospective Studies on Asthma in Childhood
Copenhagen University Hospital, Herlev-Gentofte
phone +45 3867 7360
contact@copsac.com
COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌
COPSAC